| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 |
| filingDate |
2006-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fd04957edb783a40d52f60d039670b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b972ba4d8af709c56d82db4e0cb0f92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_626b847803a31fc3dbc5c74fc1a6f2ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6fe1ac6e25b41e790f2b91fc5586934 |
| publicationDate |
2011-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NZ-563369-A |
| titleOfInvention |
Controlled-release formulation useful for treating disorders associated with hepatitus C virus |
| abstract |
Disclosed are controlled release dosage formulations comprising a compound of formula (Ia), (Ib) or (Ic) and a controlled-release carrier wherein the carrier is a swellable polymer. Also disclosed is the use of the above formulation for the manufacture of a medicament for treating or ameliorating one or more symptoms of HCV or disorders associated with HCV. |
| priorityDate |
2005-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |